D.E. Shaw & Co’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.7M | Sell |
540,801
-15,616
| -3% | -$568K | 0.01% | 718 |
|
2025
Q1 | $20.1M | Buy |
556,417
+270,338
| +94% | +$9.79M | 0.02% | 676 |
|
2024
Q4 | $12M | Buy |
286,079
+24,485
| +9% | +$1.03M | 0.01% | 912 |
|
2024
Q3 | $14.5M | Buy |
261,594
+58,152
| +29% | +$3.23M | 0.01% | 792 |
|
2024
Q2 | $8.36M | Buy |
+203,442
| New | +$8.36M | 0.01% | 983 |
|
2023
Q4 | – | Sell |
-6,152
| Closed | -$219K | – | 3304 |
|
2023
Q3 | $219K | Sell |
6,152
-88,777
| -94% | -$3.16M | ﹤0.01% | 2557 |
|
2023
Q2 | $4.38M | Sell |
94,929
-25,959
| -21% | -$1.2M | ﹤0.01% | 1312 |
|
2023
Q1 | $4.85M | Sell |
120,888
-169,107
| -58% | -$6.78M | 0.01% | 1352 |
|
2022
Q4 | $13.4M | Sell |
289,995
-182,359
| -39% | -$8.45M | 0.01% | 796 |
|
2022
Q3 | $19.6M | Buy |
472,354
+112,837
| +31% | +$4.67M | 0.02% | 566 |
|
2022
Q2 | $21.4M | Sell |
359,517
-124,821
| -26% | -$7.45M | 0.03% | 569 |
|
2022
Q1 | $35.2M | Sell |
484,338
-62,253
| -11% | -$4.52M | 0.03% | 446 |
|
2021
Q4 | $46M | Buy |
546,591
+70,884
| +15% | +$5.96M | 0.04% | 377 |
|
2021
Q3 | $42.9M | Sell |
475,707
-290,390
| -38% | -$26.2M | 0.04% | 403 |
|
2021
Q2 | $73M | Buy |
766,097
+14,929
| +2% | +$1.42M | 0.06% | 277 |
|
2021
Q1 | $85.5M | Buy |
751,168
+35,881
| +5% | +$4.09M | 0.08% | 224 |
|
2020
Q4 | $99M | Buy |
715,287
+284,395
| +66% | +$39.4M | 0.09% | 201 |
|
2020
Q3 | $35.4M | Buy |
430,892
+93,728
| +28% | +$7.7M | 0.04% | 412 |
|
2020
Q2 | $26.4M | Sell |
337,164
-61,310
| -15% | -$4.8M | 0.03% | 475 |
|
2020
Q1 | $17.7M | Buy |
398,474
+84,306
| +27% | +$3.75M | 0.03% | 533 |
|
2019
Q4 | $13.4M | Buy |
314,168
+125,785
| +67% | +$5.37M | 0.02% | 738 |
|
2019
Q3 | $8.06M | Buy |
188,383
+54,777
| +41% | +$2.34M | 0.01% | 935 |
|
2019
Q2 | $8.48M | Sell |
133,606
-10,571
| -7% | -$671K | 0.01% | 928 |
|
2019
Q1 | $10M | Sell |
144,177
-177,657
| -55% | -$12.3M | 0.01% | 834 |
|
2018
Q4 | $14M | Buy |
321,834
+316,434
| +5,860% | +$13.8M | 0.02% | 658 |
|
2018
Q3 | $412K | Buy |
+5,400
| New | +$412K | ﹤0.01% | 2155 |
|
2017
Q4 | – | Sell |
-12,682
| Closed | -$675K | – | 2624 |
|
2017
Q3 | $675K | Sell |
12,682
-54,193
| -81% | -$2.88M | ﹤0.01% | 1956 |
|
2017
Q2 | $4.15M | Buy |
66,875
+29,212
| +78% | +$1.81M | 0.01% | 1110 |
|
2017
Q1 | $2.55M | Buy |
+37,663
| New | +$2.55M | ﹤0.01% | 1264 |
|
2016
Q1 | – | Sell |
-58,488
| Closed | -$6.56M | – | 2704 |
|
2015
Q4 | $6.56M | Buy |
58,488
+47,790
| +447% | +$5.36M | 0.01% | 829 |
|
2015
Q3 | $1.03M | Buy |
10,698
+5,398
| +102% | +$520K | ﹤0.01% | 1719 |
|
2015
Q2 | $543K | Sell |
5,300
-21,428
| -80% | -$2.2M | ﹤0.01% | 2139 |
|
2015
Q1 | $1.66M | Buy |
+26,728
| New | +$1.66M | ﹤0.01% | 1469 |
|